Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LILRB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ISCA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CBLC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPM1H - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VSNL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGF18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRSF6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PACRG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF350 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ANKRD36 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RNF7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A3P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARID1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927539 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYLPF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SETSIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABLIM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF124 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DPT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on